PE20070950A1 - Sales de adicion de acido de n-{3-[4-(2-metoxifenil)-1-piperazinil]-propil}-7-oxo-5-trifluormetil-7h-tieno[3,2-b]piran-3-carboxamida - Google Patents
Sales de adicion de acido de n-{3-[4-(2-metoxifenil)-1-piperazinil]-propil}-7-oxo-5-trifluormetil-7h-tieno[3,2-b]piran-3-carboxamidaInfo
- Publication number
- PE20070950A1 PE20070950A1 PE2007000119A PE2007000119A PE20070950A1 PE 20070950 A1 PE20070950 A1 PE 20070950A1 PE 2007000119 A PE2007000119 A PE 2007000119A PE 2007000119 A PE2007000119 A PE 2007000119A PE 20070950 A1 PE20070950 A1 PE 20070950A1
- Authority
- PE
- Peru
- Prior art keywords
- metoxifenil
- piperazinil
- oxo
- propyl
- salts
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 150000003857 carboxamides Chemical class 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- -1 METHANSULPHONIC ACID Chemical class 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000000428 dust Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A SALES DE ADICION DE N-{3-[4-(2-METOXIFENIL)-1-PIPERAZINIL]-PROPIL}-7-OXO-5-TRIFLUORMETIL-7H-TIENO[3,2-b]PIRAN-3-CARBOXAMIDA (COMPUESTO A) CON ACIDOS INORGANICOS TAL COMO EL ACIDO CLORHIDRICO O BROMHIDRICO, ACIDOS SULFONICOS TAL COMO EL ACIDO METANSULFONICO, BENCENSULFONICO, TOLUENSULFONICO O NAFTALEN-1,5-DISULFONICO, O ACIDO CARBOXILICO. SIENDO UNA SAL PREFERIDA LA FORMA CRISTALINA DEL MESILATO DE N-{3-[4-(2-METOXIFENIL)-1-PIPERAZINIL]-PROPIL}-7-OXO-5-TRIFLUORMETIL-7H-TIENO[3,2-b]PIRAN-3-CARBOXAMIDA CUYOS PICOS DEL PATRON DE DIFRACCION DE POLVO DE RAYOS X EXPRESADO EN GRADOS 2 SON 10,97; 14,67; 15,73; 16,49; 18,75; 20,76; 22,07; 22,73; 24,35; 26,65 Y 27,74. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHAS SALES DE ADICION DEL COMPUESTO A SON UTILES PARA EL TRATAMIENTO DE SINDROMES OBSTRUCTIVOS DEL TRACTO URINARIO INFERIOR TAL COMO HIPERTROFIA PROSTATICA BENIGNA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76482406P | 2006-02-03 | 2006-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070950A1 true PE20070950A1 (es) | 2007-09-10 |
Family
ID=37983328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000119A PE20070950A1 (es) | 2006-02-03 | 2007-02-02 | Sales de adicion de acido de n-{3-[4-(2-metoxifenil)-1-piperazinil]-propil}-7-oxo-5-trifluormetil-7h-tieno[3,2-b]piran-3-carboxamida |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070185129A1 (es) |
| AR (1) | AR059302A1 (es) |
| PE (1) | PE20070950A1 (es) |
| TW (1) | TW200804395A (es) |
| UY (1) | UY30111A1 (es) |
| WO (1) | WO2007088063A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557807B2 (en) * | 2008-01-24 | 2013-10-15 | Signal Rx Pharmaceuticals, Inc. | Thienopyranones as kinase inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1313581B1 (it) * | 1999-07-30 | 2002-09-09 | Recordati Chem Pharm | Derivati tienopirancarbossamidici. |
| US6387909B1 (en) * | 1999-07-30 | 2002-05-14 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyranecarboxamide derivatives |
| US6306861B1 (en) * | 1999-07-30 | 2001-10-23 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyrancecarboxamide derivatives |
| TWI265925B (en) * | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
| ITMI20010164A1 (it) * | 2001-01-30 | 2002-07-30 | Recordati Chem Pharm | Alfa 1 antagonisti selettivi a + d |
| US6992192B2 (en) * | 2001-06-05 | 2006-01-31 | Lilly Icos Llc. | Carboline derivatives as PDE5 inhibitors |
-
2007
- 2007-01-25 UY UY30111A patent/UY30111A1/es unknown
- 2007-02-02 PE PE2007000119A patent/PE20070950A1/es not_active Application Discontinuation
- 2007-02-02 TW TW096103902A patent/TW200804395A/zh unknown
- 2007-02-02 AR ARP070100452A patent/AR059302A1/es not_active Application Discontinuation
- 2007-02-02 WO PCT/EP2007/000901 patent/WO2007088063A1/en not_active Ceased
- 2007-02-05 US US11/671,350 patent/US20070185129A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070185129A1 (en) | 2007-08-09 |
| AR059302A1 (es) | 2008-03-26 |
| UY30111A1 (es) | 2007-04-30 |
| TW200804395A (en) | 2008-01-16 |
| WO2007088063A1 (en) | 2007-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ606001A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| AR114946A2 (es) | Formas cristalinas de 3-(2,6-dicloro-3,5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas | |
| PE20120989A1 (es) | Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo | |
| PE20070717A1 (es) | Sal de maleato y polimorfo de [2-({4-[(dimetilamino)iminometil]fenil}carbonilamino)-5-metoxifenil]-n-(5-cloro-(2-piridil))carboxamida | |
| PE20120171A1 (es) | Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acidos aminonicotinico como inhibidores de dhodh | |
| CY1112800T1 (el) | Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας | |
| WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| PE20141318A1 (es) | Liberacion modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida solubilizada utilizando acidos organicos | |
| AR072490A1 (es) | 1,2,5- oxadiazoles como inhibidores de indolamina 2,3 dioxigenasa | |
| AR057874A1 (es) | Aminopirimidinas utiles como inhibidores de quinasa | |
| PE20140188A1 (es) | Co-cristales y sales de inhibidores de ccr3 | |
| MX2007004763A (es) | Acidos carboxilicos (bifenilo) y derivados de los mismos. | |
| CO5670350A2 (es) | Proceso para preparar derivados de acido 5-(1,3-oxazol- 2-il) benzoico | |
| MY148953A (en) | Substituted biphenyl carboxylic acids and derivatives thereof | |
| BRPI0912267A2 (pt) | sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável. | |
| IT1394503B1 (it) | Sali di 6'-sialillattosio e processo per la loro sintesi e per la sintesi di altri alfa-sialiloligosaccaridi. | |
| PE20070791A1 (es) | Sal de dihidrogeno fosfato del acido 2-(3-{6-[2-(2,4-dicloro-fenil)-etilamino]-2-metoxi-pirimidin-4-il}-fenil)-2-metil-propionico | |
| GEP20135926B (en) | Trazodone and trazodone hydrochloride in purified form | |
| PE20070950A1 (es) | Sales de adicion de acido de n-{3-[4-(2-metoxifenil)-1-piperazinil]-propil}-7-oxo-5-trifluormetil-7h-tieno[3,2-b]piran-3-carboxamida | |
| HRPK20050567B3 (hr) | Perindopril | |
| MY157122A (en) | 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl]thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzene-sulfonate, crystal of same, polymorph thereof, and processes for production thereof | |
| BRPI0510278A (pt) | método para produzir compostos, produto, e, composto | |
| CO6270318A2 (es) | Acido 4-[4-(2adamantilcarbomoil)-5-tert-butilpirazol -1-il]benzoico-465 | |
| IL200323A0 (en) | Synthesis of glyt-1 inhibitors | |
| AP2005003259A0 (en) | New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |